Codexis Files to Raise $100 Million in Initial Public Offering
Posted in Biofuels, Investment on December 31st, 2009 by News Desk –Redwood City, Calif. – Codexis, a Redwood City-based biotechnology company that focuses on the biofuels industry, has filed with the Securities and Exchange Commission for its initial public offering of stock to raise an estimated $100 million.
Founded in 2002, Codexis provides biocatalysts that make existing industrial processes faster, cleaner and more efficient and that have the potential to make new industrial processes possible at commercial scale.
The company has commercialized its biocatalysts in the pharmaceutical industry and is developing biocatalysts for use in producing advanced biofuels under a multi-year research and development collaboration with Royal Dutch Shell.
Codexis is also using its technology platform to pursue biocatalyst-enabled products in other bioindustrial markets, including carbon management, water treatment and chemicals.
The company had revenue of about $58.7 million in the first nine months of 2009 and a loss of $15 million. Its investors include Bio*One Capital, Chevron Technology Ventures, CMEA Capital, FirstMark Capital, GE Energy, Maxygen, Pfizer, and Shell.
